Evidence map›Paper›PMID 40066328›Full record

ArticleVirus evolution2025

Improvements in RNA and DNA nanopore sequencing allow for rapid genetic characterization of avian influenza.

Albert Perlas, Tim Reska, Guillaume Croville, Ferran Tarrés-Freixas, Jean-Luc Guérin, Natàlia Majó, Lara Urban

Abstract read
In one paragraph

Article in Virus evolution, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Nanopore sequencing in veterinary medicine: from concepts to clinical applications.Frontiers in cellular and infection microbiology · 2025
    Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Albert PerlasComputational Health Center, Helmholtz Zentrum Muenchen, Ingolstaedter Landstr. 1, Neuherberg 85764, Germany.
Tim ReskaComputational Health Center, Helmholtz Zentrum Muenchen, Ingolstaedter Landstr. 1, Neuherberg 85764, Germany.
Guillaume CrovilleIHAP, Université de Toulouse, INRAE, ENVT, Toulouse 31300, France.
Ferran Tarrés-FreixasIRTA. Programa de Sanitat Animal., Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), Bellaterra 08193, Spain.
Jean-Luc GuérinIHAP, Université de Toulouse, INRAE, ENVT, Toulouse 31300, France.
Natàlia MajóUnitat mixta d'investigació IRTA-UAB en Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), Bellaterra, Catalonia 08193, Spain.
Lara UrbanComputational Health Center, Helmholtz Zentrum Muenchen, Ingolstaedter Landstr. 1, Neuherberg 85764, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Avian influenza virus (AIV) currently causes a panzootic with extensive mortality in wild birds, poultry, and wild mammals, thus posing a major threat to global health and underscoring the need for efficient monitoring of its distribution and evolution. We here utilized a well-defined AIV strain to systematically investigate AIV genetic characterization through rapid, portable nanopore sequencing by comparing the latest DNA and RNA nanopore sequencing approaches and various computational pipelines for viral consensus sequence generation and phylogenetic analysis. We show that the latest direct RNA nanopore sequencing updates improve consensus sequence generation, but that the application of the latest DNA nanopore chemistry after reverse transcription and amplification outperforms, such native viral RNA sequencing by achieving higher sequencing accuracy and throughput. We additionally leveraged the direct RNA nanopore sequencing data for the detection of RNA modifications, such as

Indexed as

Avian influenzananopore sequencingRNA modificationsviral evolution

Identifiers

PMID40066328
PMCPMC11892550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.